MicroTech Medical Hong Kong IPO Greeted with Yawns 微泰医疗香港上市遇冷
Diabetes device maker’s shares go largely unchanged in first four trading days despite attracting Invesco and two other mid-sized U.S. fund managers 尽管吸引了景顺和其他两家美国中型基金，这家糖尿病设备制造商的股价在前四个交易日基本没有变化。
Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.